Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Ann Card Anaesth ; 2018 Apr; 21(2): 158-166
Article | IMSEAR | ID: sea-185704

ABSTRACT

Context: Cardiac tamponade (CT) following cardiac surgery is a potentially fatal complication and the cause of surgical reintervention in 0.1%–6% of cases. There are two types of CT: acute, occurring within the first 48 h postoperatively, and subacute or delayed, which occurs more than 48 h postoperatively. The latter does not show specific clinical signs, which makes it more difficult to diagnose. The factors associated with acute CT (aCT) are related to coagulopathy or surgical bleeding, while the variables associated with subacute tamponade have not been well defined. Aims: The primary objective of this study was to identify the factors associated with the development of subacute CT (sCT). Settings and Design: This report describes a case (n = 80) and control (n = 160) study nested in a historic cohort made up of adult patients who underwent any type of urgent or elective cardiac surgery in a tertiary cardiovascular hospital. Methods: The occurrence of sCT was defined as the presence of a compatible clinical picture, pericardial effusion and confirmation of cardiac tamponade during the required emergency intervention at any point between 48 hours and 30 days after surgery. All factors potentially related to the development of sCT were taken into account. Statistical Analysis Used: For the adjusted analysis, a logistical regression was constructed with 55 variables, including pre-, intra-, and post-operative data. Results: The mortality of patients with sCT was 11% versus 0% in the controls. Five variables were identified as independently and significantly associated with the outcome: pre- or post-operative anticoagulation, reintervention in the first 48 h, surgery other than coronary artery bypass graft, and red blood cell transfusion. Conclusions: Our study identified five variables associated with sCT and established that this complication has a high mortality rate. These findings may allow the implementation of standardized follow-up measures for patients identified as higher risk, leading to either early detection or prevention.

2.
Univ. med ; 53(3): 235-248, jul.-sept. 2012. tab, graf
Article in Spanish | LILACS | ID: lil-682057

ABSTRACT

Introducción: El reparo endovascular de la aorta torácica (REVAT) se ha incrementado en el mundo en los últimos años con relación al abierto. Objetivo: Comparar los resultados clínicos del REVAT frente al reparo abierto en la Fundación Cardio Infantil (Bogotá, Colombia) entre 2002 y 2011. Metodología: Análisis retrospectivo de la cohorte de pacientes sometidos a reparo abierto (grupo 1) en comparación de REVAT (grupo 2). En cada uno de los grupos se evaluó tiempo quirúrgico, tasa de morbilidad, mortalidad, reintervención y estancia hospitalaria. Resultados: Se incluyeron 57 pacientes en el análisis (26 % reparo abierto; 74 % REVAT). Se reintervinieron dos pacientes por endofugas tipo 1 en el grupo 2 y un caso por sangrado en el grupo 1. La mortalidad operatoria fue para el grupo 1 de 20 %, y para el grupo 2, de 2,3 %. El tiempo quirúrgico fue de 398 ± 180 min (grupo 1) versus 85,5 ± 35 min (grupo 2 (p = 0,0001) y el tiempo de estancia hospitalaria promedio fue de 9,8 días (grupo 1) y 5,3 días (grupo 2) [p = 0,01]). El tiempo promedio de seguimiento fue 4,8 ± 3,1 años. Conclusiones: El REVAT parece ofrecer menor morbilidad, mortalidad, tiempo quirúrgico y estancia hospitalaria respecto al reparo abierto, aunque las poblaciones de pacientes incluidos no fueron estrictamente comparables. Se requieren nuevos análisis en un diseño prospectivo, idealmente aleatorizado para documentar los beneficios a largo plazo de este tipo de reparo...


Introduction: Thoracic Endovascular Aortic Repair(TEVAR) has increased worldwide morethan open repair in the last few years. Objective:To compare clinical outcomes of TEVARversus open surgery at Fundación Cardio Infantil(Bogota, Colombia), between 2002 and 2011.Methods: Retrospective analysis of the cohort ofpatients with open repair (group 1) in comparisonto TEVAR (group 2). In each group, surgicaltime, morbidity rates (infection, hemorrhage,medular ischemia, cerebrovascular event, andpostoperative renal failure), mortality, reintervention,and hospital stay were evaluated. For comparisonsa univariate analysis was used, being a p< 0.05 statistically significant. Results: 57 patientswere included (26 % open repair; 74 % TEVAR).Two type 1 endoleaks on group 2 and 1 bleedingpatient in group 1 required a second surgery. Surgicalmortality was 20 % in group 1, and 2.3 % ingroup 2); surgical time was 398 ± 180 (group 1)versus 85.5 ± 35 min (group 2) (p = 0.0001); andhospital stay was 9,8 days (group 1) and 5.3 days(group 2). Average follow-up time was 4.8 ± 3.1years. Conclusions: TEVAR may be associatedwith less morbidity, mortality, surgical time, andhospital stay than open repair, although the populationsincluded were not strictly comparable.New, prospective studies, ideally randomized,are needed to support the long term benefits ofthis type of repair...


Subject(s)
Aortic Aneurysm , Aorta, Thoracic/surgery , Aorta, Thoracic/injuries , Aortic Diseases , Endovascular Procedures
4.
Acta méd. colomb ; 15(1): 12-20, ene.-feb. 1990. tab
Article in Spanish | LILACS | ID: lil-84404

ABSTRACT

La falla hepatica fulminante (FHF) conlleva una mortalidad muy elevada en todas las series informadas a nivel mundial, a pesar de un tratamiento medico energico, por lo cual en muchos casos debe recurrirse al trasplante ortotopico de higado (TOH). Se presenta la experiencia en el manejo de FHF en la Fundacion Santa Fe de Bogota (FSFB) entre mayo de 1988 y mayo de 1989 con nueve casos que fueron tratados utilizando un protocolo de manejo. La mortalidad en nuestra serie fue de 66%, incluyendo un caso que requirio TOH y tres que fallecieron esperando donante. Es llamativa la alta frecuencia de hipatitis viral en la etiologia de FHF en este grupo


Subject(s)
Humans , Male , Female , Liver Diseases , Colombia , Liver Transplantation
SELECTION OF CITATIONS
SEARCH DETAIL